ECSP12011930A - Nuevos compuestos de espiropiperidina - Google Patents
Nuevos compuestos de espiropiperidinaInfo
- Publication number
- ECSP12011930A ECSP12011930A ECSP12011930A ECSP12011930A EC SP12011930 A ECSP12011930 A EC SP12011930A EC SP12011930 A ECSP12011930 A EC SP12011930A EC SP12011930 A ECSP12011930 A EC SP12011930A
- Authority
- EC
- Ecuador
- Prior art keywords
- spyropiperidine
- compounds
- new
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26518109P | 2009-11-30 | 2009-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP12011930A true ECSP12011930A (es) | 2012-07-31 |
Family
ID=43384775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP12011930 ECSP12011930A (es) | 2009-11-30 | 2012-05-20 | Nuevos compuestos de espiropiperidina |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8822486B2 (OSRAM) |
| EP (1) | EP2507228B1 (OSRAM) |
| JP (1) | JP5709889B2 (OSRAM) |
| KR (1) | KR101410103B1 (OSRAM) |
| CN (1) | CN102648195B (OSRAM) |
| AR (1) | AR078948A1 (OSRAM) |
| AU (1) | AU2010324987B2 (OSRAM) |
| BR (1) | BR112012012903A2 (OSRAM) |
| CA (1) | CA2781292C (OSRAM) |
| CL (1) | CL2012001321A1 (OSRAM) |
| CR (1) | CR20120296A (OSRAM) |
| DO (1) | DOP2012000139A (OSRAM) |
| EA (1) | EA020507B1 (OSRAM) |
| EC (1) | ECSP12011930A (OSRAM) |
| ES (1) | ES2526568T3 (OSRAM) |
| GT (1) | GT201200164A (OSRAM) |
| IL (1) | IL219594A0 (OSRAM) |
| MA (1) | MA33840B1 (OSRAM) |
| MX (1) | MX2012006233A (OSRAM) |
| NZ (1) | NZ600203A (OSRAM) |
| PE (1) | PE20121474A1 (OSRAM) |
| PH (1) | PH12012501052A1 (OSRAM) |
| TN (1) | TN2012000248A1 (OSRAM) |
| TW (1) | TW201141866A (OSRAM) |
| WO (1) | WO2011066183A1 (OSRAM) |
| ZA (1) | ZA201203055B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR078522A1 (es) | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
| US8476287B2 (en) | 2009-12-25 | 2013-07-02 | Mochida Pharmaceutical Co., Ltd. | 3-hydroxy-5-arylisothiazole derivative |
| JP5809157B2 (ja) | 2010-10-08 | 2015-11-10 | 持田製薬株式会社 | 環状アミド誘導体 |
| JP5420796B2 (ja) | 2011-04-27 | 2014-02-19 | 持田製薬株式会社 | 新規３−ヒドロキシイソチアゾール１−オキシド誘導体 |
| CA2834465A1 (en) | 2011-04-28 | 2012-11-01 | Mochida Pharmaceutical Co., Ltd. | Cyclic amide derivative |
| TWI537262B (zh) | 2011-08-17 | 2016-06-11 | 美國禮來大藥廠 | 供治療糖尿病使用之新穎１，２，３，４－四氫喹啉衍生物 |
| US10118922B2 (en) | 2013-03-14 | 2018-11-06 | Janssen Pharmaceutica Nv | GPR120 agonists for the treatment of type II diabetes |
| EA201690888A1 (ru) | 2013-11-14 | 2016-10-31 | Кадила Хелзкэр Лимитед | Новые гетероциклические соединения |
| EP3076959B1 (en) | 2013-12-04 | 2018-07-04 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| US10059667B2 (en) | 2014-02-06 | 2018-08-28 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
| KR102708681B1 (ko) | 2018-02-13 | 2024-09-26 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| EP3781556B1 (en) | 2018-04-19 | 2025-06-18 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| CN118221646A (zh) | 2018-07-13 | 2024-06-21 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
| KR102635333B1 (ko) | 2018-10-24 | 2024-02-15 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| CN110590767B (zh) * | 2019-08-29 | 2021-10-08 | 南方科技大学 | 一种合成amg837的方法 |
| WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
| EP4153589A4 (en) | 2020-05-19 | 2024-06-12 | Kallyope, Inc. | AMPK ACTIVATORS |
| WO2021263039A1 (en) | 2020-06-26 | 2021-12-30 | Kallyope, Inc. | Ampk activators |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0202133D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
| MXPA05010724A (es) * | 2003-04-04 | 2005-12-15 | Merck & Co Inc | Derivados de las espiropiperidinas aciladas como agonistas del receptor de la melanocortina-4. |
| JP2007510662A (ja) | 2003-11-04 | 2007-04-26 | エリクシアー ファーマシューティカルズ， インコーポレイテッド | 治療化合物およびその使用 |
| BRPI0508098A (pt) | 2004-02-27 | 2007-07-17 | Amgen Inc | compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos |
| US7517910B2 (en) * | 2004-03-30 | 2009-04-14 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| ATE429426T1 (de) * | 2004-09-07 | 2009-05-15 | Banyu Pharma Co Ltd | Carbamoylsubstituiertes spiro-derivat |
| CN101553493B (zh) * | 2006-07-19 | 2012-07-04 | 阿斯利康(瑞典)有限公司 | 三环螺哌啶化合物、它们的合成和它们作为趋化因子受体活性调节剂的用途 |
| WO2008038692A1 (en) * | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diaryl ketimine derivative |
| CA2674154A1 (en) * | 2006-12-29 | 2008-07-10 | F. Hoffmann-La Roche Ag | Azaspiro derivatives |
| EP2139843B1 (en) * | 2007-04-16 | 2013-12-25 | Amgen, Inc | Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
| PT2202216E (pt) | 2007-10-26 | 2012-07-19 | Japan Tobacco Inc | Composto espiro em anel e sua utilização para objectivos médicos |
| AR078522A1 (es) * | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
-
2010
- 2010-11-08 AR ARP100104151A patent/AR078948A1/es not_active Application Discontinuation
- 2010-11-10 TW TW099138725A patent/TW201141866A/zh unknown
- 2010-11-19 KR KR1020127013788A patent/KR101410103B1/ko not_active Expired - Fee Related
- 2010-11-19 CA CA2781292A patent/CA2781292C/en not_active Expired - Fee Related
- 2010-11-19 WO PCT/US2010/057359 patent/WO2011066183A1/en not_active Ceased
- 2010-11-19 BR BR112012012903A patent/BR112012012903A2/pt not_active IP Right Cessation
- 2010-11-19 PE PE2012000730A patent/PE20121474A1/es not_active Application Discontinuation
- 2010-11-19 CN CN201080054116.3A patent/CN102648195B/zh not_active Expired - Fee Related
- 2010-11-19 EA EA201290416A patent/EA020507B1/ru not_active IP Right Cessation
- 2010-11-19 MX MX2012006233A patent/MX2012006233A/es not_active Application Discontinuation
- 2010-11-19 AU AU2010324987A patent/AU2010324987B2/en not_active Ceased
- 2010-11-19 ES ES10784390.6T patent/ES2526568T3/es active Active
- 2010-11-19 NZ NZ600203A patent/NZ600203A/xx not_active IP Right Cessation
- 2010-11-19 US US13/505,470 patent/US8822486B2/en not_active Expired - Fee Related
- 2010-11-19 PH PH1/2012/501052A patent/PH12012501052A1/en unknown
- 2010-11-19 JP JP2012542076A patent/JP5709889B2/ja not_active Expired - Fee Related
- 2010-11-19 EP EP10784390.6A patent/EP2507228B1/en active Active
-
2012
- 2012-04-25 ZA ZA2012/03055A patent/ZA201203055B/en unknown
- 2012-05-03 IL IL219594A patent/IL219594A0/en unknown
- 2012-05-15 DO DO2012000139A patent/DOP2012000139A/es unknown
- 2012-05-20 EC ECSP12011930 patent/ECSP12011930A/es unknown
- 2012-05-22 TN TNP2012000248A patent/TN2012000248A1/en unknown
- 2012-05-23 CL CL2012001321A patent/CL2012001321A1/es unknown
- 2012-05-28 GT GT201200164A patent/GT201200164A/es unknown
- 2012-05-30 CR CR20120296A patent/CR20120296A/es not_active Application Discontinuation
- 2012-06-21 MA MA34993A patent/MA33840B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011066183A1 (en) | 2011-06-03 |
| JP5709889B2 (ja) | 2015-04-30 |
| PH12012501052A1 (en) | 2013-02-04 |
| EP2507228B1 (en) | 2014-11-05 |
| TW201141866A (en) | 2011-12-01 |
| GT201200164A (es) | 2014-02-27 |
| BR112012012903A2 (pt) | 2017-03-01 |
| DOP2012000139A (es) | 2012-08-15 |
| EP2507228A1 (en) | 2012-10-10 |
| EA020507B1 (ru) | 2014-11-28 |
| US8822486B2 (en) | 2014-09-02 |
| ZA201203055B (en) | 2013-09-25 |
| CR20120296A (es) | 2012-07-16 |
| AU2010324987A1 (en) | 2012-07-26 |
| IL219594A0 (en) | 2012-06-28 |
| TN2012000248A1 (en) | 2013-12-12 |
| MA33840B1 (fr) | 2012-12-03 |
| US20120220616A1 (en) | 2012-08-30 |
| CA2781292C (en) | 2014-04-22 |
| MX2012006233A (es) | 2012-07-03 |
| KR20120088770A (ko) | 2012-08-08 |
| CA2781292A1 (en) | 2011-06-03 |
| NZ600203A (en) | 2013-09-27 |
| EA201290416A1 (ru) | 2012-11-30 |
| JP2013512277A (ja) | 2013-04-11 |
| AR078948A1 (es) | 2011-12-14 |
| CL2012001321A1 (es) | 2013-11-15 |
| AU2010324987B2 (en) | 2014-01-30 |
| CN102648195B (zh) | 2015-01-07 |
| CN102648195A (zh) | 2012-08-22 |
| ES2526568T3 (es) | 2015-01-13 |
| KR101410103B1 (ko) | 2014-06-25 |
| PE20121474A1 (es) | 2012-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6531458A2 (es) | Nuevos compuestos de espiropiperidina | |
| ECSP12011930A (es) | Nuevos compuestos de espiropiperidina | |
| BR112012026767A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal | |
| UY32062A (es) | Inhibidores de beta-secretasa | |
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| IN2014KN00948A (OSRAM) | ||
| GT201400022A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes | |
| MX2013007336A (es) | Compuestos de bi-heteroarilo como inhibidores de vps34. | |
| UY32153A (es) | Inhibidores de piridomidinona de pi13ka(alfa) y mtor | |
| EA201491028A1 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| SG194463A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes | |
| EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
| CL2014001154A1 (es) | Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana. | |
| AR085616A1 (es) | Composicion farmaceutica inhalable que comprende glicopirrolato, uso | |
| BR112014008783A2 (pt) | compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório | |
| CR20140325A (es) | Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2- | |
| CO6460763A2 (es) | Métodos y formulaciones ectoparasiticidas | |
| AR080025A1 (es) | Derivados de 8-aza-biciclo[3,2,1] oct-3-iloxi)-cromen-2-ona, utiles como inhibidores de la recaptacion del neurotransmisor monoamina | |
| CL2013002584A1 (es) | Compuestos derivados de 2-(2-metilpropanoil)pirazolidin-3-carboxamida, inhibidores de la peptido desformilasa (pdf); composición farmaceutica, utiles en el tratamiento de una infeccion bacteriana. | |
| CO6382120A2 (es) | Compuestos ciclopropilo | |
| CL2011000120A1 (es) | Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas. | |
| CL2007003806A1 (es) | Compuestos derivados de n-(2h-pirazol-3-il)-amida, inhibidores del fgfr; composicion farmaceutica que comprende a dichos compuestos; su proceso de preparacion; y su uso para el tratamiento del cancer. | |
| BRPI1015983A2 (pt) | composto, uso do composto, método para tratar um paciente, e, composição farmacêutica. | |
| MX2011003390A (es) | Compuestos y composiciones útiles en el tratamiento de enfermedades cardiacas con efectos secundarios reducidos. | |
| CO6300947A2 (es) | Derivados de 6,7-dialcoxi quinazolina utiles para el tratamiento de cancer |